For example, in human neuroblastoma, MYC amplification distorts circadian repressors (NR1D1) and circadian activators (RORA and BMAL1) to cause metabolic rewiring that fuels cancer cell growth and promotes poor patient outcomes [15,39]. The gene discussed is BMAL1; the disease is neuroblastoma.